Praxis Precision Medicines, Inc. SEC filings PRAX
Praxis Precision Medicines, Inc. has 511 filings in SEC EDGAR's recent list, going back to Nov 10, 2016. Its latest annual report, Form 10-K, was filed on Feb 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Feb 19, 2026 | — |
| 424B5 | Prospectus supplement | Jan 7, 2026 | — |
| 424B5 | Prospectus supplement | Jan 6, 2026 | — |
| 424B5 | Prospectus supplement | Oct 20, 2025 | — |
| 424B5 | Prospectus supplement | Oct 16, 2025 | — |
| 424B5 | Prospectus supplement | Sep 5, 2025 | — |
| S-8 | Employee stock plan registration | Feb 28, 2025 | — |
| S-8 | Employee stock plan registration | Feb 28, 2025 | — |
| S-3ASR | Automatic shelf registration | Dec 23, 2024 | — |
| S-8 POS | Form s-8 pos | Jun 10, 2024 | — |
| 424B5 | Prospectus supplement | Mar 29, 2024 | — |
| 424B5 | Prospectus supplement | Mar 27, 2024 | — |
| S-3 | Shelf registration | Mar 5, 2024 | — |
| S-8 | Employee stock plan registration | Mar 5, 2024 | — |
| S-8 | Employee stock plan registration | Jan 31, 2024 | — |
| 424B5 | Prospectus supplement | Jan 12, 2024 | — |
| 424B5 | Prospectus supplement | Jan 10, 2024 | — |
| 424B5 | Prospectus supplement | Dec 7, 2023 | — |
| 424B5 | Prospectus supplement | Jun 20, 2023 | — |
| FWP | Free writing prospectus | Jun 16, 2023 | — |
| 424B5 | Prospectus supplement | Jun 15, 2023 | — |
| S-8 | Employee stock plan registration | Feb 7, 2023 | — |
| POS AM | Filing | Feb 7, 2023 | — |
| S-8 | Employee stock plan registration | Feb 28, 2022 | — |
| S-3ASR | Automatic shelf registration | Nov 3, 2021 | — |
| POS AM | Filing | May 17, 2021 | — |
| 424B4 | Prospectus | May 14, 2021 | — |
| S-1 | Registration statement | May 11, 2021 | — |
| S-8 | Employee stock plan registration | Mar 17, 2021 | — |
| S-8 | Employee stock plan registration | Oct 16, 2020 | — |
| 424B4 | Prospectus | Oct 16, 2020 | — |
| S-1/A | Amended registration statement | Oct 15, 2020 | — |
| S-1/A | Amended registration statement | Oct 9, 2020 | — |
| S-1 | Registration statement | Sep 25, 2020 | — |
Showing 34 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PRAX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1689548
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.